2026 NPPES data Infectious Disease Physician NPI 1487624045 M.D.
Verify on CMS →

MELVIN KHAW, M.D.

Infectious Disease Physician in ENCINO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 450 beneficiaries · Infectious Disease Physician avg: 816
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
85.7185/100
▲ 3 pts above national avg 83.1 · [object Object]
Industry payments
$25.81
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MELVIN KHAW, M.D. reported a CMS MIPS final score of 85.7185/100 — above the 83.1 national average — and filed 4,671 Medicare Part D claims in 2023.

85.7185/100
MIPS score · +3 vs avg
5K
Part D claims, 2023
88%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MELVIN KHAW, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

86 49th percentile higher than 49% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MELVIN KHAW, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MELVIN KHAW, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 01/25/2006

NPI 1487624045

Primary specialty

Infectious Disease Physician

Mid-sized

8,292 US NPIs in this specialty

Medicare Part D claims

4,671 472% vs specialty avg

2023 prescription claims

Specialty avg: 816

MIPS final score

85.7185/100 2.6185000000000116% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Infectious Disease Physician compares to other specialties among California providers

California providers

Infectious Disease Physician share within California

1. Infectious Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Infectious Disease Physician share within California

Medicare quality performance — MIPS

MELVIN KHAW, M.D.'s 2023 MIPS final score plotted against the Infectious Disease Physician national average

High performer (top quartile)
MIPS Final Score
85.7185/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Infectious Disease Physician) — 85.7185/100 vs national avg 83.1

0%100%National avg83%85.7%
MIPS final score (Infectious Disease Physician) — 85.7185/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MELVIN KHAW, M.D. appears in the CMS NPPES registry as a Infectious Disease Physician provider holding M.D. credentials at 16030 VENTURA BLVD, ENCINO, CA, 91436, with a listed phone of (818) 990-1067. NPI 1487624045 was issued on 01/25/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KHAW most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,671 prescription claims written by this provider, covering 450 Medicare beneficiaries and totaling roughly $426K in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 1.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 85.7185/100 for the 2023 performance year (Quality 85.6751, Cost 61.479), compared with the national average of 83.1.

Infectious Disease Physician is a mid-sized specialty nationwide, with 8,292 enrolled providers across 54 states and an average of 816 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

16030 VENTURA BLVD
ENCINO, CA 91436

Provider Details

NPI 1487624045
Specialty Infectious Disease Physician
Credentials M.D.
Gender Male
NPI Issued 01/25/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

85.7185
Final Score
Avg: 83.1
85.6751
Quality
61.479
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MELVIN KHAW, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CEDARS-SINAI MEDICAL CARE FOUNDATION
ENCINO, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MELVIN KHAW, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$26

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MELVIN KHAW, M.D.. To verify MELVIN KHAW, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MELVIN KHAW, M.D. — brand share 12.0%
Specialty average (est.)

12% brand-name claims vs 88% generic, on 4,671 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,671
Total Claims
$426K
Total Drug Cost
450
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
10,228
Total Day Supply
294,036
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$314K
Generic Drug Cost
$109K
Opioid Claims
71 (1.5% rate)
Antibiotic Claims
221

Patient Demographics

Average Patient Age
77.7 years
Avg HCC Risk Score
1.06
Gender Split
56% female / 44% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MELVIN KHAW, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
395
Levothyroxine Sodium
237
Rosuvastatin Calcium
201
Amlodipine Besylate
198
Lisinopril
149
Zolpidem Tartrate
123
Azithromycin
98
Alprazolam
95
Irbesartan
93
Montelukast Sodium
91

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Infectious Disease Physician Overview

How MELVIN KHAW, M.D. fits within the Infectious Disease Physician landscape nationally.

8,292
Infectious Disease Physician Providers in US
54
States with Infectious Disease Physician
816
Avg Claims per Provider

MELVIN KHAW, M.D.'s 4,671 claims are above the specialty average of 816.

Nearby Infectious Disease Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as KHAW.

Compare Infectious Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MELVIN KHAW, M.D.'s specialty?
MELVIN KHAW, M.D. specializes in Infectious Disease Physician and practices in ENCINO, California. Credentials: M.D..
How much does MELVIN KHAW, M.D. prescribe under Medicare Part D?
In 2023, MELVIN KHAW, M.D. wrote 4,671 Medicare Part D claims totaling $426K in drug costs for 450 beneficiaries.
What is MELVIN KHAW, M.D.'s Medicare quality score?
MELVIN KHAW, M.D. has a CMS MIPS Final Score of 85.7185/100 (Quality: 85.6751, Cost: 61.479). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MELVIN KHAW, M.D. located?
MELVIN KHAW, M.D. is located at 16030 VENTURA BLVD, ENCINO, CA, 91436. Phone: (818) 990-1067.
What is MELVIN KHAW, M.D.'s NPI number?
MELVIN KHAW, M.D.'s National Provider Identifier (NPI) is 1487624045, issued on 01/25/2006.
Does MELVIN KHAW, M.D. prescribe more brand-name or generic drugs?
MELVIN KHAW, M.D.'s prescribing is 12% brand-name and 88% generic drugs by claim count, with $314K in brand drug costs.
Does MELVIN KHAW, M.D. prescribe opioids?
Yes, MELVIN KHAW, M.D. had 71 opioid claims in 2023 with an opioid prescribing rate of 1.5%.
How many Infectious Disease Physician providers are there in the US?
There are 8,292 Infectious Disease Physician providers across 54 states in the US. The average Infectious Disease Physician provider writes 816 Medicare Part D claims per year.
What drugs does MELVIN KHAW, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MELVIN KHAW, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Levothyroxine Sodium, Rosuvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MELVIN KHAW, M.D. accept Medicare?
MELVIN KHAW, M.D. appears in CMS Medicare data with 4,671 Part D claims and 450 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MELVIN KHAW, M.D.'s credentials?
MELVIN KHAW, M.D.'s NPI is 1487624045 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology